Clinical Study
Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial
Figure 3
Cumulative graphic representation () of Mon2 subset circulating fractions [(a); ANOVA ] and counts [(b); ANOVA ] in the three CAD severity groups. CAD1: no CAD/minimal CAD; CAD2: non-obstructive CAD; CAD3: obstructive CAD.
(a) |
(b) |